<VariationArchive VariationID="167710" VariationName="NM_000543.5(SMPD1):c.573del (p.Ser192fs)" VariationType="Deletion" Accession="VCV000167710" Version="31" RecordType="classified" NumberOfSubmissions="10" NumberOfSubmitters="10" DateLastUpdated="2024-07-15" DateCreated="2015-06-28" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="178086" VariationID="167710">
      <GeneList>
        <Gene Symbol="SMPD1" FullName="sphingomyelin phosphodiesterase 1" GeneID="6609" HGNC_ID="HGNC:11120" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="6390474" stop="6394996" display_start="6390474" display_stop="6394996" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="6411643" stop="6416227" display_start="6411643" display_stop="6416227" Strand="+" />
          </Location>
          <OMIM>607608</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000543.5(SMPD1):c.573del (p.Ser192fs)</Name>
      <CanonicalSPDI>NC_000011.10:6391637:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p15.4</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="6391638" stop="6391638" display_start="6391638" display_stop="6391638" variantLength="1" positionVCF="6391637" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="6412868" stop="6412868" display_start="6412868" display_stop="6412868" variantLength="1" positionVCF="6412867" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>S191fs</ProteinChange>
      <ProteinChange>S192fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000543.4" sequenceAccession="NM_000543" sequenceVersion="4" change="c.573del">
            <Expression>NM_000543.4:c.573del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.6391638del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.6391638del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.6412868del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.6412868del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011780.1" sequenceAccession="NG_011780" sequenceVersion="1" change="g.6214del">
            <Expression>NG_011780.1:g.6214del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000543.5" sequenceAccession="NM_000543" sequenceVersion="5" change="c.573del" MANESelect="true">
            <Expression>NM_000543.5:c.573del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000534.3" sequenceAccession="NP_000534" sequenceVersion="3" change="p.Ser192fs">
            <Expression>NP_000534.3:p.Ser192fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001007593.3" sequenceAccession="NM_001007593" sequenceVersion="3" change="c.570del">
            <Expression>NM_001007593.3:c.570del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001007594.2" sequenceAccession="NP_001007594" sequenceVersion="2" change="p.Ser191fs">
            <Expression>NP_001007594.2:p.Ser191fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318087.2" sequenceAccession="NM_001318087" sequenceVersion="2" change="c.573del">
            <Expression>NM_001318087.2:c.573del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001305016.1" sequenceAccession="NP_001305016" sequenceVersion="1" change="p.Ser192fs">
            <Expression>NP_001305016.1:p.Ser192fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318088.2" sequenceAccession="NM_001318088" sequenceVersion="2" change="c.-389del">
            <Expression>NM_001318088.2:c.-389del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001365135.2" sequenceAccession="NM_001365135" sequenceVersion="2" change="c.573del">
            <Expression>NM_001365135.2:c.573del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001352064.1" sequenceAccession="NP_001352064" sequenceVersion="1" change="p.Ser192fs">
            <Expression>NP_001352064.1:p.Ser192fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_027400.3" sequenceAccession="NR_027400" sequenceVersion="3" change="n.698del">
            <Expression>NR_027400.3:n.698del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA234968" DB="ClinGen" />
        <XRef Type="rs" ID="727504167" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000543.5(SMPD1):c.573del (p.Ser192fs) AND not provided" Accession="RCV000175623" Version="14">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-09-01" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000543.5(SMPD1):c.573del (p.Ser192fs) AND Niemann-Pick disease, type A" Accession="RCV000586553" Version="10">
        <ClassifiedConditionList TraitSetID="758">
          <ClassifiedCondition DB="MedGen" ID="C0268242">Niemann-Pick disease, type A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-31" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000543.5(SMPD1):c.573del (p.Ser192fs) AND Niemann-Pick disease, type B" Accession="RCV000983993" Version="1">
        <ClassifiedConditionList TraitSetID="759">
          <ClassifiedCondition DB="MedGen" ID="C0268243">Niemann-Pick disease, type B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2018-01-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000543.5(SMPD1):c.573del (p.Ser192fs) AND multiple conditions" Accession="RCV000824303" Version="6">
        <ClassifiedConditionList TraitSetID="9472">
          <ClassifiedCondition DB="MedGen" ID="C0268242">Niemann-Pick disease, type A</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268243">Niemann-Pick disease, type B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000543.5(SMPD1):c.573del (p.Ser192fs) AND Sphingomyelin/cholesterol lipidosis" Accession="RCV001248979" Version="3">
        <ClassifiedConditionList TraitSetID="8114">
          <ClassifiedCondition DB="MedGen" ID="C0028064">Sphingomyelin/cholesterol lipidosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-01-22" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-31" NumberOfSubmissions="10" NumberOfSubmitters="10" DateCreated="2015-06-28" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10694919</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12369017</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15221801</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15241805</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20386867</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25811928</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26499107</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26913189</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=SMPD1</URL>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/e505057a-c328-4a34-8eaf-f4c95bf3a245</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="759" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3636" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Niemann-Pick disease, type B</ElementValue>
                <XRef ID="Niemann-Pick+Disease%2C+Type+B/5227" DB="Genetic Alliance" />
                <XRef ID="39390005" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The phenotype of acid sphingomyelinase deficiency (ASMD) occurs along a continuum. Individuals with the severe early-onset form, infantile neurovisceral ASMD, were historically diagnosed with Niemann-Pick disease type A (NPD-A). The later-onset, chronic visceral form of ASMD is also referred to as Niemann-Pick disease type B (NPD-B). A phenotype with intermediate severity is also known as chronic neurovisceral ASMD (NPD-A/B). The most common presenting symptom in NPD-A is hepatosplenomegaly, usually detectable by age three months; over time the liver and spleen become massive in size. Psychomotor development progresses no further than the 12-month level, after which neurologic deterioration is relentless. Failure to thrive typically becomes evident by the second year of life. A classic cherry-red spot of the macula of the retina, which may not be present in the first few months, is eventually present in all affected children. Interstitial lung disease caused by storage of sphingomyelin in pulmonary macrophages results in frequent respiratory infections and often respiratory failure. Most children succumb before the third year of life. NPD-B generally presents later than NPD-A, and the manifestations are less severe. NPD-B is characterized by progressive hepatosplenomegaly, gradual deterioration in liver and pulmonary function, osteopenia, and atherogenic lipid profile. No central nervous system (CNS) manifestations occur. Individuals with NPD-A/B have symptoms that are intermediate between NPD-A and NPD-B. The presentation in individuals with NPD-A/B varies greatly, although all are characterized by the presence of some CNS manifestations. Survival to adulthood can occur in individuals with NPD-B and NPD-A/B.</Attribute>
                <XRef ID="NBK1370" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000556508" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501749" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556495" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596376" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558532" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556520" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246735" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000051492" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501745" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10729" />
                <XRef ID="10729" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301544</ID>
                <ID Source="BookShelf">NBK1370</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Niemann-Pick.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased acid sphingomyelinase, Acid Sphingomyelinase Deficiency (ASMD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/ASMD-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Acid Sphingomyelinase Deficiency (ASMD): Decreased Acid Sphingomyelinase (ASM), 2022</CitationText>
              </Citation>
              <XRef ID="77293" DB="Orphanet" />
              <XRef ID="C0268243" DB="MedGen" />
              <XRef ID="MONDO:0011871" DB="MONDO" />
              <XRef Type="MIM" ID="607616" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="758" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5650" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SPHINGOMYELIN LIPIDOSIS</ElementValue>
                <XRef Type="MIM" ID="257200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPHINGOMYELINASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="257200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Niemann-Pick disease, type A</ElementValue>
                <XRef ID="Niemann-Pick+Disease%2C+Type+A/5226" DB="Genetic Alliance" />
                <XRef ID="52165006" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The phenotype of acid sphingomyelinase deficiency (ASMD) occurs along a continuum. Individuals with the severe early-onset form, infantile neurovisceral ASMD, were historically diagnosed with Niemann-Pick disease type A (NPD-A). The later-onset, chronic visceral form of ASMD is also referred to as Niemann-Pick disease type B (NPD-B). A phenotype with intermediate severity is also known as chronic neurovisceral ASMD (NPD-A/B). The most common presenting symptom in NPD-A is hepatosplenomegaly, usually detectable by age three months; over time the liver and spleen become massive in size. Psychomotor development progresses no further than the 12-month level, after which neurologic deterioration is relentless. Failure to thrive typically becomes evident by the second year of life. A classic cherry-red spot of the macula of the retina, which may not be present in the first few months, is eventually present in all affected children. Interstitial lung disease caused by storage of sphingomyelin in pulmonary macrophages results in frequent respiratory infections and often respiratory failure. Most children succumb before the third year of life. NPD-B generally presents later than NPD-A, and the manifestations are less severe. NPD-B is characterized by progressive hepatosplenomegaly, gradual deterioration in liver and pulmonary function, osteopenia, and atherogenic lipid profile. No central nervous system (CNS) manifestations occur. Individuals with NPD-A/B have symptoms that are intermediate between NPD-A and NPD-B. The presentation in individuals with NPD-A/B varies greatly, although all are characterized by the presence of some CNS manifestations. Survival to adulthood can occur in individuals with NPD-B and NPD-A/B.</Attribute>
                <XRef ID="NBK1370" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000556507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558532" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501745" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556520" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246735" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569983" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501749" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556508" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507864" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596376" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556495" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000051492" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000571198" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7206" />
                <XRef ID="7206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301544</ID>
                <ID Source="BookShelf">NBK1370</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Niemann-Pick.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased acid sphingomyelinase, Acid Sphingomyelinase Deficiency (ASMD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/ASMD-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Acid Sphingomyelinase Deficiency (ASMD): Decreased Acid Sphingomyelinase (ASM), 2022</CitationText>
              </Citation>
              <XRef ID="77292" DB="Orphanet" />
              <XRef ID="C0268242" DB="MedGen" />
              <XRef ID="MONDO:0009756" DB="MONDO" />
              <XRef Type="MIM" ID="257200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9472" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3636" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Niemann-Pick disease, type B</ElementValue>
                <XRef ID="Niemann-Pick+Disease%2C+Type+B/5227" DB="Genetic Alliance" />
                <XRef ID="39390005" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The phenotype of acid sphingomyelinase deficiency (ASMD) occurs along a continuum. Individuals with the severe early-onset form, infantile neurovisceral ASMD, were historically diagnosed with Niemann-Pick disease type A (NPD-A). The later-onset, chronic visceral form of ASMD is also referred to as Niemann-Pick disease type B (NPD-B). A phenotype with intermediate severity is also known as chronic neurovisceral ASMD (NPD-A/B). The most common presenting symptom in NPD-A is hepatosplenomegaly, usually detectable by age three months; over time the liver and spleen become massive in size. Psychomotor development progresses no further than the 12-month level, after which neurologic deterioration is relentless. Failure to thrive typically becomes evident by the second year of life. A classic cherry-red spot of the macula of the retina, which may not be present in the first few months, is eventually present in all affected children. Interstitial lung disease caused by storage of sphingomyelin in pulmonary macrophages results in frequent respiratory infections and often respiratory failure. Most children succumb before the third year of life. NPD-B generally presents later than NPD-A, and the manifestations are less severe. NPD-B is characterized by progressive hepatosplenomegaly, gradual deterioration in liver and pulmonary function, osteopenia, and atherogenic lipid profile. No central nervous system (CNS) manifestations occur. Individuals with NPD-A/B have symptoms that are intermediate between NPD-A and NPD-B. The presentation in individuals with NPD-A/B varies greatly, although all are characterized by the presence of some CNS manifestations. Survival to adulthood can occur in individuals with NPD-B and NPD-A/B.</Attribute>
                <XRef ID="NBK1370" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000556508" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501749" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556495" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596376" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558532" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556520" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246735" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000051492" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501745" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10729" />
                <XRef ID="10729" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301544</ID>
                <ID Source="BookShelf">NBK1370</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Niemann-Pick.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased acid sphingomyelinase, Acid Sphingomyelinase Deficiency (ASMD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/ASMD-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Acid Sphingomyelinase Deficiency (ASMD): Decreased Acid Sphingomyelinase (ASM), 2022</CitationText>
              </Citation>
              <XRef ID="77293" DB="Orphanet" />
              <XRef ID="C0268243" DB="MedGen" />
              <XRef ID="MONDO:0011871" DB="MONDO" />
              <XRef Type="MIM" ID="607616" DB="OMIM" />
            </Trait>
            <Trait ID="5650" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SPHINGOMYELIN LIPIDOSIS</ElementValue>
                <XRef Type="MIM" ID="257200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPHINGOMYELINASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="257200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Niemann-Pick disease, type A</ElementValue>
                <XRef ID="Niemann-Pick+Disease%2C+Type+A/5226" DB="Genetic Alliance" />
                <XRef ID="52165006" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The phenotype of acid sphingomyelinase deficiency (ASMD) occurs along a continuum. Individuals with the severe early-onset form, infantile neurovisceral ASMD, were historically diagnosed with Niemann-Pick disease type A (NPD-A). The later-onset, chronic visceral form of ASMD is also referred to as Niemann-Pick disease type B (NPD-B). A phenotype with intermediate severity is also known as chronic neurovisceral ASMD (NPD-A/B). The most common presenting symptom in NPD-A is hepatosplenomegaly, usually detectable by age three months; over time the liver and spleen become massive in size. Psychomotor development progresses no further than the 12-month level, after which neurologic deterioration is relentless. Failure to thrive typically becomes evident by the second year of life. A classic cherry-red spot of the macula of the retina, which may not be present in the first few months, is eventually present in all affected children. Interstitial lung disease caused by storage of sphingomyelin in pulmonary macrophages results in frequent respiratory infections and often respiratory failure. Most children succumb before the third year of life. NPD-B generally presents later than NPD-A, and the manifestations are less severe. NPD-B is characterized by progressive hepatosplenomegaly, gradual deterioration in liver and pulmonary function, osteopenia, and atherogenic lipid profile. No central nervous system (CNS) manifestations occur. Individuals with NPD-A/B have symptoms that are intermediate between NPD-A and NPD-B. The presentation in individuals with NPD-A/B varies greatly, although all are characterized by the presence of some CNS manifestations. Survival to adulthood can occur in individuals with NPD-B and NPD-A/B.</Attribute>
                <XRef ID="NBK1370" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000556507" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570054" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558532" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501745" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556520" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000246735" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592960" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569983" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501749" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000551442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556508" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000570010" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330870" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507864" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596376" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569406" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556495" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000051492" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592442" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000556506" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000571198" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7206" />
                <XRef ID="7206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301544</ID>
                <ID Source="BookShelf">NBK1370</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2008">
                <ID Source="PubMed">18197057</ID>
                <ID Source="pmc">3110977</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2009">
                <ID Source="PubMed">19888064</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Niemann-Pick.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased acid sphingomyelinase, Acid Sphingomyelinase Deficiency (ASMD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/ASMD-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Acid Sphingomyelinase Deficiency (ASMD): Decreased Acid Sphingomyelinase (ASM), 2022</CitationText>
              </Citation>
              <XRef ID="77292" DB="Orphanet" />
              <XRef ID="C0268242" DB="MedGen" />
              <XRef ID="MONDO:0009756" DB="MONDO" />
              <XRef Type="MIM" ID="257200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8114" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="14993" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Niemann-Pick disease</ElementValue>
                <XRef ID="MONDO:0001982" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Sphingomyelin/cholesterol lipidosis</ElementValue>
                <XRef ID="Niemann-Pick+disease/5222" DB="Genetic Alliance" />
                <XRef ID="58459009" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The phenotype of acid sphingomyelinase deficiency (ASMD) occurs along a continuum. Individuals with the severe early-onset form, infantile neurovisceral ASMD, were historically diagnosed with Niemann-Pick disease type A (NPD-A). The later-onset, chronic visceral form of ASMD is also referred to as Niemann-Pick disease type B (NPD-B). A phenotype with intermediate severity is also known as chronic neurovisceral ASMD (NPD-A/B). The most common presenting symptom in NPD-A is hepatosplenomegaly, usually detectable by age three months; over time the liver and spleen become massive in size. Psychomotor development progresses no further than the 12-month level, after which neurologic deterioration is relentless. Failure to thrive typically becomes evident by the second year of life. A classic cherry-red spot of the macula of the retina, which may not be present in the first few months, is eventually present in all affected children. Interstitial lung disease caused by storage of sphingomyelin in pulmonary macrophages results in frequent respiratory infections and often respiratory failure. Most children succumb before the third year of life. NPD-B generally presents later than NPD-A, and the manifestations are less severe. NPD-B is characterized by progressive hepatosplenomegaly, gradual deterioration in liver and pulmonary function, osteopenia, and atherogenic lipid profile. No central nervous system (CNS) manifestations occur. Individuals with NPD-A/B have symptoms that are intermediate between NPD-A and NPD-B. The presentation in individuals with NPD-A/B varies greatly, although all are characterized by the presence of some CNS manifestations. Survival to adulthood can occur in individuals with NPD-B and NPD-A/B.</Attribute>
                <XRef ID="NBK1370" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13334" />
                <XRef ID="13334" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301544</ID>
                <ID Source="BookShelf">NBK1370</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Niemann-Pick.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Decreased acid sphingomyelinase, Acid Sphingomyelinase Deficiency (ASMD), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/ASMD-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Acid Sphingomyelinase Deficiency (ASMD): Decreased Acid Sphingomyelinase (ASM), 2022</CitationText>
              </Citation>
              <XRef ID="C0028064" DB="MedGen" />
              <XRef ID="MONDO:0001982" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1789591" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-24" DateCreated="2019-05-24">
        <ClinVarSubmissionID localKey="945457" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000914525" DateUpdated="2019-05-24" DateCreated="2019-05-24" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-07-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10694919</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15221801</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15241805</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20386867</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26913189</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26499107</ID>
          </Citation>
          <Comment>The SMPD1 c.573delT (p.Ser192AlafsTer65) variant (also reported as 677delT; c.567delT; p.P189fs; fsP189) results in a frameshift and is predicted to result in premature termination of the protein. Across a selection of the available literature, the p.Ser192AlafsTer65 variant has been identified in a total of 26 individuals with acid sphingomyelinase deficiency including 20 homozygotes and one compound heterozygote with Niemann-Pick disease type A and five compound heterozygotes with Niemann-Pick disease type B, (Gluck et al. 1998; Ricci et al. 2004; Pittis et al. 2004; Desnick et al. 2010; Oyama et al. 2012; Dalal et al. 2015; Zampieri et al. 2016). Twelve of the homozygous patients are of Israeli Arab ethnicity from the lower Galilee and Samaria region, an area where consanguinity is common although none of these families were noted as consanguineous. The other eight homozygous patients, as well as at least one of the compound heterozygous patients are from Southern Italy, where it has been suggested the population is genetically similar to the Middle East. The second variant found in the compound heterozygous patients was either a missense variant (four individuals), a nonsense variant (one individual) or a frameshift variant (one individual). Two of the compound heterozygous individuals were noted to have 11% and 21.7% residual enzyme activity compared to wild type respectively (Pittis et al. 2004; Desnick et al. 2010). The p.Ser192AlafsTer65variant was absent from 50 healthy Italian controls and is not found in the 1000 Genomes Project, the Exome Sequencing Project, Exome Aggregation Consortium or the Genome Aggregation Database. Based on the evidence from the literature and the potential impact of frameshift variants, the p.Ser192AlafsTer65 variant is classified as pathogenic for SMPD1-Related Disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="C" referenceAllele="CT" start="6412867" stop="6412868" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000543.4:c.573delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="257200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1547326" SubmissionDate="2019-08-05" DateLastUpdated="2019-12-23" DateCreated="2018-03-17">
        <ClinVarSubmissionID localKey="25015|OMIM:607616" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000797023" DateUpdated="2019-12-23" DateCreated="2018-03-17" Type="SCV" Version="2" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-01-09">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20386867</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26913189</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="C" referenceAllele="CT" start="6412867" stop="6412868" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607616" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6133108</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2857354" SubmissionDate="2020-10-23" DateLastUpdated="2020-11-28" DateCreated="2020-11-28">
        <ClinVarSubmissionID localKey="report_configuration_variant_id:335294" />
        <ClinVarAccession Accession="SCV001446966" DateUpdated="2020-11-28" DateCreated="2020-11-28" Type="SCV" Version="1" SubmitterName="Institute of Medical Genetics and Applied Genomics, University Hospital TÃ¼bingen" OrgID="506385" OrganizationCategory="laboratory" OrgAbbreviation="IMGAG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SampleLocalID">DX202755</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001406" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001433" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001531" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="C" referenceAllele="CT" start="6412867" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4080184" SubmissionDate="2022-02-09" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_000543.5:c.573del|Niemann-Pick Disease, Types A/B" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002091687" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000543.5:c.573del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Niemann-Pick Disease, Types A/B</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1859583" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4573795|MedGen:C0268243;C0268242" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000965196" DateUpdated="2024-02-28" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12369017</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15221801</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10694919</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20386867</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25811928</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26913189</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ser192Alafs*65) in the SMPD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SMPD1 are known to be pathogenic (PMID: 12369017, 15221801). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individuals with Niemann-Pick disease (PMID: 10694919, 20386867, 25811928, 26913189). This variant is also known as c.677delT. ClinVar contains an entry for this variant (Variation ID: 167710). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.6412868del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268243" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268242" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7851937" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000543.5:c.573del|OMIM:257200" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004203218" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000543.5:c.573del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="257200" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1363770" SubmissionDate="2018-01-25" DateLastUpdated="2018-03-17" DateCreated="2018-03-17">
        <ClinVarSubmissionID localKey="NM_000543.4:c.573delT|MedGen:C0268242" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000697418" DateUpdated="2018-03-17" DateCreated="2018-03-17" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-05-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26499107</ID>
          </Citation>
          <Comment>Variant summary: The SMPD1 c.573delT (p.Ser192Alafs) variant (alternatively also known as 667delA and 567delA) results in a premature termination codon, predicted to cause a truncated or absent SMPD1 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic/likely pathogenic by our laboratory (e.g. c.996delC, c.1785_1786delCC, etc.). This variant is absent from 23568 control chromosomes from ExAC. This variant has been reported in several patients with Niemann-Pick disease (NPD). In homozygous state and in compound heterozygous with other severe mutations, it is found to cause type 1 NPD. It was found to be a common pathogenic variant in Israeli Arabs and Turkish patient population (Gluck_1998, Aykut_2013). On clinical laboratory in ClinVar has classified it as pathogenic. Taken together, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
            <CitationText>LabCorp Variant Classification Summary - May 2015.docx</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="727504167" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000543.4:c.573delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268242" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2016-2017-variants</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="415463" SubmissionDate="2017-06-30" DateLastUpdated="2015-06-28" DateCreated="2015-06-28">
        <ClinVarSubmissionID localKey="5675_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000227147" DateUpdated="2015-06-28" DateCreated="2015-06-28" Type="SCV" Version="5" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000203606" DateChanged="2018-02-14" Version="2" />
        </ReplacedList>
        <Classification DateLastEvaluated="2013-11-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions</Attribute>
          <Citation>
            <URL>http://www.egl-eurofins.com/emvclass/EGLClassificationDefinitions.php</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="3" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="-" referenceAllele="T" start="6412868" stop="6412868" variantLength="1" />
            <GeneLocation>NM_000543.4:Ex2</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD972451" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=SMPD1</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>EGL005</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2805232" SubmissionDate="2020-03-09" DateLastUpdated="2022-02-01" DateCreated="2020-07-19">
        <ClinVarSubmissionID localKey="e505057a-c328-4a34-8eaf-f4c95bf3a245|MedGen:C0028064" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001422821" DateUpdated="2022-02-01" DateCreated="2020-07-19" Type="SCV" Version="2" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15221801</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26499107</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26913189</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15241805</ID>
          </Citation>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/e505057a-c328-4a34-8eaf-f4c95bf3a245</URL>
          </Citation>
          <Comment>The p.Ser192AlafsTer65 variant in SMPD1 (also known as p.Ser190AlafsTer65 due to a difference in cDNA numbering) has been reported in at least 12 individuals with Niemann-Pick disease (PMID: 15241805, 15221801, 26913189, 26499107), but data from large population studies is insufficient to assess the frequency of this variant. This variant has also been reported in ClinVar (VariationID: 167710) as pathogenic by EGL Genetic Diagnostics, Integrated Genetics, Counsyl, and Illumina Clinical Services Laboratory. This variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at position 192 and leads to a premature termination codon 65 amino acids downstream. Loss of function of the SMPD1 gene is an established disease mechanism in autosomal recessive Niemann-Pick disease. The presence of this variant in 8 affected homozygotes and in combination with a reported pathogenic variant and in an individual with Niemann-Pick disease increases the likelihood that the p.Ser192Alafs variant is pathogenic (VariationID: 188840; PMID: 15241805, 15221801). The phenotype of an individual compound heterozygous for this variant is highly specific for Niemann-Pick disease based on acid sphingomyelinase activity being &lt;10% of normal, consistent with disease (PMID: 26913189). In summary, this variant meets criteria to be classified as pathogenic for Niemann-Pick disease in an autosomal recessive manner based on the prediction that it will cause loss of function, the presence of the variant in affected homozygotes and compound heterozygous, and the phenotype of individuals with the variant being highly specific for disease. ACMG/AMP Criteria applied: PVS1, PM3, PP4 (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Abbrev="ACMG, 2015" Type="practice guideline">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000543.4(SMPD1):c.573delT</Name>
            <Name>p.Ser192Alafs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.10:g.6391638delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Sphingomyelin/cholesterol lipidosis</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0028064" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6906750</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7565171" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2023-10-14">
        <ClinVarSubmissionID localKey="133524|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004042508" DateUpdated="2024-07-15" DateCreated="2023-10-14" Type="SCV" Version="8" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>SMPD1: PVS1, PM3:Strong, PM2, PP4:Moderate</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMPD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="C" referenceAllele="CT" start="6412867" stop="6412868" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7565171" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2857354" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001406" MappingRef="HP">
        <MedGen CUI="C0008372" Name="Intrahepatic cholestasis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7851937" TraitType="Disease" MappingType="XRef" MappingValue="257200" MappingRef="OMIM">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1547326" TraitType="Disease" MappingType="XRef" MappingValue="607616" MappingRef="OMIM">
        <MedGen CUI="C0268243" Name="Niemann-Pick disease, type B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2805232" TraitType="Disease" MappingType="Name" MappingValue="Sphingomyelin/cholesterol lipidosis" MappingRef="Preferred">
        <MedGen CUI="C0028064" Name="Sphingomyelin/cholesterol lipidosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1859583" TraitType="Disease" MappingType="XRef" MappingValue="C0268242" MappingRef="MedGen">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2857354" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001433" MappingRef="HP">
        <MedGen CUI="C0019214" Name="Hepatosplenomegaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2857354" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1859583" TraitType="Disease" MappingType="XRef" MappingValue="C0268243" MappingRef="MedGen">
        <MedGen CUI="C0268243" Name="Niemann-Pick disease, type B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="415463" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1789591" TraitType="Disease" MappingType="XRef" MappingValue="257200" MappingRef="OMIM">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2857354" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001531" MappingRef="HP">
        <MedGen CUI="C1867873" Name="Failure to thrive in infancy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4080184" TraitType="Disease" MappingType="Name" MappingValue="Niemann-Pick Disease, Types A/B" MappingRef="Preferred">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1363770" TraitType="Disease" MappingType="XRef" MappingValue="C0268242" MappingRef="MedGen">
        <MedGen CUI="C0268242" Name="Niemann-Pick disease, type A" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

